Shire ROA 2006-2018 | SHPG

Current and historical return on assets (ROA) values for Shire (SHPG) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $15.161B
Shire Pharmaceuticals Group plc is a specialty pharmaceutical company focused primarily on two therapeutic areas: central nervous system disorders and metabolic bone diseases. (press release)
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $41.588B 32.81
Grifols (GRFS) Spain $14.291B 18.52
Jazz Pharmaceuticals (JAZZ) Ireland $10.613B 17.85
Neurocrine Biosciences (NBIX) United States $9.279B 0.00
Nektar Therapeutics (NKTR) United States $8.207B 0.00
Sage Therapeutics (SAGE) United States $7.815B 0.00
Catalent (CTLT) United States $5.759B 26.82
Ionis Pharmaceuticals (IONS) United States $5.622B 0.00
FibroGen (FGEN) United States $5.441B 0.00
Loxo Oncology (LOXO) United States $5.376B 0.00
United Therapeutics (UTHR) United States $5.362B 9.73
Taro Pharmaceutical Industries (TARO) Israel $4.509B 18.48
Madrigal Pharmaceuticals (MDGL) United States $4.090B 0.00
Ironwood Pharmaceuticals (IRWD) United States $3.024B 0.00
Aerie Pharmaceuticals (AERI) United States $2.907B 0.00
Heron Therapeutics (HRTX) United States $2.716B 0.00
USANA Health Sciences (USNA) United States $2.658B 25.57
Portola Pharmaceuticals (PTLA) United States $2.640B 0.00
Endo (ENDP) Ireland $2.509B 3.42
Spectrum Pharmaceuticals (SPPI) United States $2.500B 0.00
Enanta Pharmaceuticals (ENTA) United States $2.420B 44.70
Xencor (XNCR) United States $2.336B 0.00
TESARO (TSRO) United States $2.246B 0.00
Zogenix (ZGNX) United States $2.085B 0.00
PTC Therapeutics (PTCT) United States $1.625B 0.00
Corcept Therapeutics (CORT) United States $1.568B 26.17
Pacira Pharmaceuticals (PCRX) United States $1.509B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.460B 0.00
TherapeuticsMD (TXMD) United States $1.432B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.398B 0.00
Impax Laboratories (AMRX) United States $1.363B 29.29
ImmunoGen (IMGN) United States $1.338B 0.00
Radius Health (RDUS) United States $1.290B 0.00
Esperion Therapeutics (ESPR) United States $1.172B 0.00
Endocyte (ECYT) United States $1.168B 0.00
TRICIDA INC (TCDA) United States $1.157B 0.00
OptiNose (OPTN) United States $1.024B 0.00
Flexion Therapeutics (FLXN) United States $1.017B 0.00
Karyopharm Therapeutics (KPTI) United States $0.933B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.797B 0.00
GlycoMimetics (GLYC) United States $0.676B 0.00
Dova Pharmaceuticals (DOVA) United States $0.669B 0.00
Collegium Pharmaceutical (COLL) United States $0.646B 0.00
TRANSLATE BIO (TBIO) United States $0.631B 0.00
Aclaris Therapeutics (ACRS) United States $0.624B 0.00
CASI Pharmaceuticals (CASI) United States $0.624B 0.00
Odonate Therapeutics (ODT) United States $0.617B 0.00
ChemoCentryx (CCXI) United States $0.612B 42.97
BioCryst Pharmaceuticals (BCRX) United States $0.611B 0.00
Akebia Therapeutics (AKBA) United States $0.586B 0.00
Siga Technologies (SIGA) United States $0.557B 0.00
Depomed (DEPO) United States $0.522B 0.00
ArQule (ARQL) United States $0.489B 0.00
Lannett Co Inc (LCI) United States $0.483B 4.44
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.482B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.469B 0.00
VERRICA PHARMA (VRCA) United States $0.459B 0.00
FORTY SEVEN INC (FTSV) United States $0.458B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.453B 0.00
Majesco Entertainment (COOL) United States $0.452B 0.00
Dermira (DERM) United States $0.429B 0.00
Concert Pharmaceuticals (CNCE) United States $0.389B 0.00
XERIS PHARMA (XERS) United States $0.386B 0.00
Mast Therapeutics (SVRA) United States $0.380B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.335B 26.18
Bellicum Pharmaceuticals (BLCM) United States $0.327B 0.00
Achaogen (AKAO) United States $0.323B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.318B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.316B 0.00
NEON THERAPEUTC (NTGN) United States $0.314B 0.00
Minerva Neurosciences (NERV) United States $0.314B 0.00
Tyme Technologies (TYME) United States $0.302B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.300B 0.00
Zafgen (ZFGN) United States $0.294B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.255B 0.00
Jounce Therapeutics (JNCE) United States $0.254B 0.00
DURECT (DRRX) United States $0.243B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.242B 0.00
Redhill Biopharma (RDHL) Israel $0.235B 0.00
Ocular Therapeutix (OCUL) United States $0.234B 0.00
Galectin Therapeutics (GALT) United States $0.226B 0.00
ProNAi Therapeutics (SRRA) Canada $0.224B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.223B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.220B 0.00
Immune Design (IMDZ) United States $0.217B 0.00
Ardelyx (ARDX) United States $0.212B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.211B 0.00
Aratana Therapeutics (PETX) United States $0.208B 0.00
IMV INC (IMV) Canada $0.202B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.200B 0.00
Melinta Therapeutics (MLNT) United States $0.193B 0.00
ContraFect (CFRX) United States $0.183B 0.00
Neos Therapeutics (NEOS) United States $0.180B 0.00
Nature's Sunshine Products (NATR) United States $0.173B 0.00
Adherex Technologies (FENC) United States $0.173B 0.00
MediWound (MDWD) Israel $0.170B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.166B 0.00
Calithera Biosciences (CALA) United States $0.163B 0.00
Aldeyra Therapeutics (ALDX) United States $0.162B 0.00
MEI Pharma (MEIP) United States $0.149B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.149B 0.00
Opexa Therapeutics (ACER) United States $0.148B 0.00
Cardiome Pharma (CORV) Canada $0.137B 0.00
Molecular Templates (MTEM) United States $0.133B 0.00
CTI BioPharma (CTIC) United States $0.131B 0.00
Forward Pharma (FWP) Denmark $0.130B 0.00
Juniper Pharmaceuticals (JNP) United States $0.127B 190.83
Adamis Pharmaceuticals (ADMP) United States $0.125B 0.00
SteadyMed (STDY) Israel $0.120B 0.00
Iterum Therapeutics (ITRM) Ireland $0.117B 0.00
Nivalis Therapeutics (ALPN) United States $0.116B 0.00
Rafael Holdings (RFL) United States $0.113B 0.00
Recro Pharma (REPH) United States $0.112B 0.00
Infinity Pharmaceuticals (INFI) United States $0.110B 0.00
Affimed (AFMD) Germany $0.109B 0.00
Otonomy (OTIC) United States $0.109B 0.00
BioLineRx (BLRX) Israel $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 0.00
KalVista Pharmaceuticals (KALV) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.091B 0.00
SCYNEXIS (SCYX) United States $0.087B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.084B 0.00
Natural Alternatives (NAII) United States $0.077B 9.84
Trillium Therapeutics (TRIL) Canada $0.076B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.075B 0.00
Novan (NOVN) United States $0.073B 0.00
KemPharm (KMPH) United States $0.070B 0.00
Genocea Biosciences (GNCA) United States $0.065B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.064B 0.00
Mannatechorporated (MTEX) United States $0.055B 13.50
Capnia (SLNO) United States $0.055B 0.00
Heat Biologics (HTBX) United States $0.047B 0.00
Avenue Therapeutics (ATXI) United States $0.044B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.038B 34.17
Onconova Therapeutics (ONTX) United States $0.037B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.036B 0.00
Biomerica (BMRA) United States $0.035B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.035B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.034B 3.87
HANCOCK JAFFE (HJLI) United States $0.034B 0.00
Xenetic Biosciences (XBIO) United States $0.032B 0.00
IsoRay (ISR) United States $0.031B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.030B 0.00
Lipocine (LPCN) United States $0.030B 0.00
Regulus Therapeutics (RGLS) United States $0.030B 0.00
Shineco (TYHT) China $0.030B 2.53
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
NanoViricides (NNVC) United States $0.028B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.025B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.025B 0.00
Can-Fite Biopharma (CANF) Israel $0.025B 0.00
Cyanotech (CYAN) United States $0.024B 23.33
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Aviragen Therapeutics (VXRT) United States $0.022B 0.00
Aradigm (ARDM) United States $0.022B 0.00
ESSA Pharma (EPIX) Canada $0.022B 0.00
Midatech Pharma (MTP) United Kingdom $0.021B 0.00
Egalet (EGLT) United States $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Intellipharmaceutics (IPCI) Canada $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.015B 0.00
Pain Therapeutics (PTIE) United States $0.015B 0.00
Aralez Pharmaceuticals (ARLZ) Canada $0.015B 0.00
Skyline Medical (AIPT) United States $0.014B 0.00
India Globalization Capital (IGC) United States $0.014B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.013B 0.00
Jaguar Animal Health (JAGX) United States $0.013B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.011B 0.00
PharmAthene (ALT) United States $0.009B 0.00
Apricus Biosciences (APRI) United States $0.009B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
RXi Pharmaceuticals (RXII) United States $0.008B 0.00
Biostar Pharmaceuticals (BSPM) China $0.006B 3.21
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
ELECTROCORE LLC (ECOR) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00